Kadmon Competitors and Similar CompaniesClear all
Kadmon's competitors and similar companies include G1 Therapeutics.
 Kadmon Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C. |  G1 Therapeutics G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. | |
Founding Date | Founding Date 2010 | Founding Date 2008 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations New York, US HQ Cambridge, US South Brunswick Township, US Warrendale, US | Locations Durham, US HQ |
Employees | Employees 44 | Employees 17015% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $8.3m (FY, 2020) | Revenue (est.) $82.5m (FY, 2023) |
Net income | Net income ($108.9m) (FY, 2020) | Net income ($48m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 21.3m | Total funding raised $ 289.6m |
For sources of this data, please see the company profile
View Company Profiles
G1 Therapeutics
HQ
Durham, US
Employees
170↑ 15% increase
G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.
View company